MyoKardia_Logo_RGB.png
MyoKardia to Present at 2019 Cantor Global Healthcare Conference
September 26, 2019 16:05 ET | MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will participate in a fireside chat at...
MyoKardia_Logo_RGB.png
MyoKardia to Evaluate Mavacamten as an Alternative to Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Patients
September 10, 2019 08:44 ET | MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will study mavacamten as a therapeutic alternative to septal reduction therapy...
MyoKardia_Logo_RGB.png
MyoKardia Presents 36-week Data from PIONEER-OLE Study of Mavacamten at the European Society of Cardiology Congress 2019
August 31, 2019 05:00 ET | MyoKardia, Inc.
Durability of Mavacamten's Safety and Efficacy Profile Demonstrated through Nine Months in this Study of Patients with Symptomatic, Obstructive HCM Statistically Significant Changes in Key Biomarkers...
MyoKardia_Logo_RGB.png
MyoKardia to Participate in September Investor Conferences
August 28, 2019 16:05 ET | MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced its participation in the following upcoming investor conferences: Citi 14th Annual...
MyoKardia_Logo_RGB.png
MyoKardia Announces Abstracts Selected for Presentation at the European Society of Cardiology Congress 2019
August 26, 2019 08:30 ET | MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced the presentation of three abstracts at the upcoming European Society of Cardiology (ESC)...
MyoKardia_Logo_RGB.png
MyoKardia Reports Second Quarter 2019 Financial Results
August 07, 2019 16:05 ET | MyoKardia, Inc.
Announces Last Patient to be Enrolled in EXPLORER-HCM Phase 3 during the Week of August 12th; Topline Data Accelerated to 2nd Quarter 2020 Topline Phase 2 Clinical Data from MAVERICK-HCM and MYK-491...
MyoKardia_Logo_RGB.png
MyoKardia to Present at 2019 Wedbush PacGrow Healthcare Conference
August 07, 2019 08:00 ET | MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will present at the 2019 Wedbush PacGrow...
MyoKardia_Logo_RGB.png
MyoKardia to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019
July 31, 2019 16:05 ET | MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report second quarter 2019 financial and operating results on Wednesday,...